相关实验视频
Updated: Sep 18, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.0K
丁:在各种临床适应症中,扩大血栓治疗的视野
Vignan Yogendrakumar1,2, Yan Xu3, Ronen Gurvitch4
1Division of Neurology, University of Ottawa, The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Heart (British Cardiac Society)
|June 25, 2025
概括
与alteplase相比,tenecteplase在缺血性中风中提供了更好的结果,将治疗窗口扩展到24小时. 这是它它它它.
科学领域:
- 心脏病学和神经病学
- 血栓和纤维溶解疗法 血栓和纤维溶解疗法
背景情况:
- 静脉输血血栓抑制剂对于缺血性中风,ST升高心肌梗塞和肺栓塞至关重要.
- 一种纤维溶解剂的特内克特与阿尔特相比,具有药理学和实践上的优势.
- 对内血管治疗的限制强调了静脉注射血栓抑制剂的持续重要性.
研究的目的:
- 审查目前的证据和治疗指导方针,用于管理缺血性中风,心肌梗塞和肺栓塞.
- 突出提升在再注射疗法中基的优势和不断变化的作用.
主要方法:
- 对随机试验进行的元分析,比较中风时的丁氏甲和高氏甲.
- 对临床试验数据和对ST升高心肌梗塞和肺栓塞的治疗指南的审查.
- 讨论实用方面,包括剂量,管理和医院前使用.
主要成果:
- 甲在缺血性中风中取得出色的功能性结果方面表现出高于高甲的优势.
- 在中风中使用血栓抑制剂的治疗时间窗口已延长到24小时,并进行适当的成像.
- 在皮肤间干预延迟时,对于ST升高心肌梗塞更喜欢使用 Tenecteplase;在肺栓塞中使用它需要仔细评估风险和益处.
结论:
- 由于其有效性和实用优势,特内克特越来越多地成为首选的血栓解压剂,特别是在缺血性中风中.
- 静脉输血血栓抑制剂,包括丁氏甲基,仍然是重要的再输血治疗方法,特别是当内血管治疗无法获得时.
- 目前正在进行的研究和不断变化的指导方针继续塑造着在各种心血管和脑血管紧急情况中最优地使用 Tenecteplase.
相关概念视频
Acute Coronary Syndrome I: Introduction
81
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
81
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
48
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
48
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
655
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
655
Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K

